{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:18:18Z","timestamp":1791919098933,"version":"4.3.4"},"reference-count":67,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,4,5]],"date-time":"2018-04-05T00:00:00Z","timestamp":1522886400000},"content-version":"vor","delay-in-days":369,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002924","name":"FEDER","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002924","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Competitive Factors Operational Program"},{"name":"Portuguese Foundation for Science and Technology","award":["PTDC\/SAU-NMC\/116512\/2010, E-Rare4\/0003\/2012"],"award-info":[{"award-number":["PTDC\/SAU-NMC\/116512\/2010, E-Rare4\/0003\/2012"]}]},{"name":"EU Joint Programme - Neurodegenerative Disease Research"},{"name":"SynSpread, ESMI, and ModelPolyQ"},{"name":"Richard Chin and Lily Lock Machado Joseph Disease Research Fund"},{"DOI":"10.13039\/100002243","name":"National Ataxia Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002243","id-type":"DOI","asserted-by":"publisher"}]},{"name":"FCT"},{"name":"Marie Curie ITN - Treat PolyQ network"},{"DOI":"10.13039\/100002243","name":"National Ataxia Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002243","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["UH2 N5094355"],"award-info":[{"award-number":["UH2 N5094355"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Research Institute of The Children\u2019s Hospital of Philadelphia"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.ymthe.2017.01.021","type":"journal-article","created":{"date-parts":[[2017,2,22]],"date-time":"2017-02-22T21:15:19Z","timestamp":1487798119000},"page":"1038-1055","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":63,"title":["Unravelling Endogenous MicroRNA System Dysfunction as a New Pathophysiological Mechanism in Machado-Joseph Disease"],"prefix":"10.1016","volume":"25","author":[{"given":"Vitor","family":"Carmona","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janete","family":"Cunha-Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Onofre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Teresa","family":"Sim\u00f5es","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Udaya","family":"Vijayakumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beverly L.","family":"Davidson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu\u00eds","family":"Pereira de Almeida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2017.01.021_bib1","first-page":"17","article-title":"Machado-Joseph disease","volume":"3","author":"Sudarsky","year":"1995","journal-title":"Clin. Neurosci."},{"key":"10.1016\/j.ymthe.2017.01.021_bib2","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/ana.410390411","article-title":"Spinocerebellar ataxia 3 and Machado-Joseph disease: clinical, molecular, and neuropathological features","volume":"39","author":"D\u00fcrr","year":"1996","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ymthe.2017.01.021_bib3","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/ng1194-221","article-title":"CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1","volume":"8","author":"Kawaguchi","year":"1994","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymthe.2017.01.021_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00401-012-1000-x","article-title":"Brain pathology of spinocerebellar ataxias","volume":"124","author":"Seidel","year":"2012","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.ymthe.2017.01.021_bib5","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0896-6273(00)80943-5","article-title":"Intranuclear inclusions of expanded polyglutamine protein in spinocerebellar ataxia type 3","volume":"19","author":"Paulson","year":"1997","journal-title":"Neuron"},{"key":"10.1016\/j.ymthe.2017.01.021_bib6","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1093\/brain\/aws177","article-title":"Calpastatin-mediated inhibition of calpains in the mouse brain prevents mutant ataxin 3 proteolysis, nuclear localization and aggregation, relieving Machado-Joseph disease","volume":"135","author":"Sim\u00f5es","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.ymthe.2017.01.021_bib7","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1093\/brain\/awr047","article-title":"Overexpression of the autophagic beclin-1 protein clears mutant ataxin-3 and alleviates Machado-Joseph disease","volume":"134","author":"Nascimento-Ferreira","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.ymthe.2017.01.021_bib8","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.1093\/brain\/awv298","article-title":"Re-establishing ataxin-2 downregulates translation of mutant ataxin-3 and alleviates Machado-Joseph disease","volume":"138","author":"N\u00f3brega","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.ymthe.2017.01.021_bib9","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.biomaterials.2015.12.021","article-title":"Intravenous administration of brain-targeted stable nucleic acid lipid particles alleviates Machado-Joseph disease neurological phenotype","volume":"82","author":"Concei\u00e7\u00e3o","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/j.ymthe.2017.01.021_bib10","doi-asserted-by":"crossref","first-page":"e3341","DOI":"10.1371\/journal.pone.0003341","article-title":"Allele-specific RNA silencing of mutant ataxin-3 mediates neuroprotection in a rat model of Machado-Joseph disease","volume":"3","author":"Alves","year":"2008","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ymthe.2017.01.021_bib11","doi-asserted-by":"crossref","first-page":"e100086","DOI":"10.1371\/journal.pone.0100086","article-title":"RNA interference mitigates motor and neuropathological deficits in a cerebellar mouse model of Machado-Joseph disease","volume":"9","author":"N\u00f3brega","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ymthe.2017.01.021_bib12","doi-asserted-by":"crossref","first-page":"e52396","DOI":"10.1371\/journal.pone.0052396","article-title":"Silencing mutant ataxin-3 rescues motor deficits and neuropathology in Machado-Joseph disease transgenic mice","volume":"8","author":"N\u00f3brega","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ymthe.2017.01.021_bib13","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1038\/mt.2013.144","article-title":"Toward RNAi therapy for the polyglutamine disease Machado-Joseph disease","volume":"21","author":"Costa Mdo","year":"2013","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2017.01.021_bib14","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1038\/mt.2013.152","article-title":"Silencing mutant ATXN3 expression resolves molecular phenotypes in SCA3 transgenic mice","volume":"21","author":"Rodriguez-Lebron","year":"2013","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2017.01.021_bib15","doi-asserted-by":"crossref","first-page":"10266","DOI":"10.1523\/JNEUROSCI.2734-04.2004","article-title":"A mutant ataxin-3 putative-cleavage fragment in brains of Machado-Joseph disease patients and transgenic mice is cytotoxic above a critical concentration","volume":"24","author":"Goti","year":"2004","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.ymthe.2017.01.021_bib16","doi-asserted-by":"crossref","first-page":"7418","DOI":"10.1523\/JNEUROSCI.4540-06.2007","article-title":"Nuclear localization of ataxin-3 is required for the manifestation of symptoms in SCA3: in\u00a0vivo evidence","volume":"27","author":"Bichelmeier","year":"2007","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.ymthe.2017.01.021_bib17","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1093\/hmg\/ddn106","article-title":"Striatal and nigral pathology in a lentiviral rat model of Machado-Joseph disease","volume":"17","author":"Alves","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2017.01.021_bib18","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.nbd.2008.03.011","article-title":"Polyglutamine-expanded ataxin-3 causes cerebellar dysfunction of SCA3 transgenic mice by inducing transcriptional dysregulation","volume":"31","author":"Chou","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ymthe.2017.01.021_bib19","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/embor.2008.31","article-title":"Lentivector-mediated rescue from cerebellar ataxia in a mouse model of spinocerebellar ataxia","volume":"9","author":"Torashima","year":"2008","journal-title":"EMBO Rep."},{"key":"10.1016\/j.ymthe.2017.01.021_bib20","doi-asserted-by":"crossref","first-page":"4282","DOI":"10.1093\/hmg\/ddp381","article-title":"Reversibility of symptoms in a conditional mouse model of spinocerebellar ataxia type 3","volume":"18","author":"Boy","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2017.01.021_bib21","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.nbd.2009.08.002","article-title":"A transgenic mouse model of spinocerebellar ataxia type 3 resembling late disease onset and gender-specific instability of CAG repeats","volume":"37","author":"Boy","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ymthe.2017.01.021_bib22","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.nbd.2010.05.021","article-title":"Motor uncoordination and neuropathology in a transgenic mouse model of Machado-Joseph disease lacking intranuclear inclusions and ataxin-3 cleavage products","volume":"40","author":"Silva-Fernandes","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ymthe.2017.01.021_bib23","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/76211","article-title":"The 3\u2032 untranslated region of messenger RNA: A molecular \u2018hotspot\u2019 for pathology?","volume":"6","author":"Conne","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2017.01.021_bib24","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: genomics, biogenesis, mechanism, and function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2017.01.021_bib25","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1038\/nm.2791","article-title":"Viral delivery of miR-196a ameliorates the SBMA phenotype via the silencing of CELF2","volume":"18","author":"Miyazaki","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2017.01.021_bib26","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.ajhg.2013.05.025","article-title":"miR-196a ameliorates phenotypes of Huntington disease in cell, transgenic mouse, and induced pluripotent stem cell models","volume":"93","author":"Cheng","year":"2013","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymthe.2017.01.021_bib27","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1038\/nn.2183","article-title":"miR-19, miR-101 and miR-130 co-regulate ATXN1 levels to potentially modulate SCA1 pathogenesis","volume":"11","author":"Lee","year":"2008","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.ymthe.2017.01.021_bib28","doi-asserted-by":"crossref","first-page":"14341","DOI":"10.1523\/JNEUROSCI.2390-08.2008","article-title":"The bifunctional microRNA miR-9\/miR-9\u2217 regulates REST and CoREST and is downregulated in Huntington\u2019s disease","volume":"28","author":"Packer","year":"2008","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.ymthe.2017.01.021_bib29","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/mt.2016.13","article-title":"MiR-298 counteracts mutant androgen receptor toxicity in spinal and bulbar muscular atrophy","volume":"24","author":"Pourshafie","year":"2016","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2017.01.021_bib30","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.molcel.2006.07.030","article-title":"MicroRNA pathways modulate polyglutamine-induced neurodegeneration","volume":"24","author":"Bilen","year":"2006","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ymthe.2017.01.021_bib31","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3109\/00207454.2013.827679","article-title":"MicroRNA profiling in the serums of SCA3\/MJD patients","volume":"124","author":"Shi","year":"2014","journal-title":"Int. J. Neurosci."},{"key":"10.1016\/j.ymthe.2017.01.021_bib32","doi-asserted-by":"crossref","first-page":"4791","DOI":"10.1016\/j.febslet.2014.11.013","article-title":"miR-25 alleviates polyQ-mediated cytotoxicity by silencing ATXN3","volume":"588","author":"Huang","year":"2014","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ymthe.2017.01.021_bib33","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/2053-8871-1-7","article-title":"Current understanding of the role of microRNAs in spinocerebellar ataxias","volume":"1","author":"Koscianska","year":"2014","journal-title":"Cerebellum Ataxias"},{"key":"10.1016\/j.ymthe.2017.01.021_bib34","doi-asserted-by":"crossref","first-page":"3473","DOI":"10.1523\/JNEUROSCI.22-09-03473.2002","article-title":"Lentiviral-mediated delivery of mutant huntingtin in the striatum of rats induces a selective neuropathology modulated by polyglutamine repeat size, huntingtin expression levels, and protein length","volume":"22","author":"de Almeida","year":"2002","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.ymthe.2017.01.021_bib35","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/ng0696-196","article-title":"Expanded polyglutamine in the Machado-Joseph disease protein induces cell death in\u00a0vitro and in\u00a0vivo","volume":"13","author":"Ikeda","year":"1996","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymthe.2017.01.021_bib36","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0361-9230(01)00578-0","article-title":"Differential susceptibility of cultured cell lines to aggregate formation and cell death produced by the truncated Machado-Joseph disease gene product with an expanded polyglutamine stretch","volume":"56","author":"Yoshizawa","year":"2001","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.ymthe.2017.01.021_bib37","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1093\/hmg\/ddi472","article-title":"Proteolytic cleavage of polyglutamine-expanded ataxin-3 is critical for aggregation and sequestration of non-expanded ataxin-3","volume":"15","author":"Haacke","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2017.01.021_bib38","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.nbd.2009.07.020","article-title":"Identification and functional dissection of localization signals within ataxin-3","volume":"36","author":"Antony","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ymthe.2017.01.021_bib39","doi-asserted-by":"crossref","first-page":"6532","DOI":"10.1074\/jbc.M109.036335","article-title":"Nuclear aggregation of polyglutamine-expanded ataxin-3: fragments escape the cytoplasmic quality control","volume":"285","author":"Breuer","year":"2010","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ymthe.2017.01.021_bib40","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.tibtech.2014.09.002","article-title":"Drug target miRNAs: chances and challenges","volume":"32","author":"Schmidt","year":"2014","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.ymthe.2017.01.021_bib41","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.bmc.2007.04.055","article-title":"A fluorescence probe for assaying micro RNA maturation","volume":"16","author":"Davies","year":"2008","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ymthe.2017.01.021_bib42","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0960-9822(02)00809-6","article-title":"Identification of tissue-specific microRNAs from mouse","volume":"12","author":"Lagos-Quintana","year":"2002","journal-title":"Curr. Biol."},{"key":"10.1016\/j.ymthe.2017.01.021_bib43","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/ana.23866","article-title":"Caffeine and adenosine A(2A) receptor inactivation decrease striatal neuropathology in a lentiviral-based model of Machado-Joseph disease","volume":"73","author":"Gon\u00e7alves","year":"2013","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ymthe.2017.01.021_bib44","doi-asserted-by":"crossref","first-page":"4","DOI":"10.7554\/eLife.05005","article-title":"Predicting effective microRNA target sites in mammalian mRNAs","volume":"4","author":"Agarwal","year":"2015","journal-title":"eLife"},{"key":"10.1016\/j.ymthe.2017.01.021_bib45","doi-asserted-by":"crossref","first-page":"D239","DOI":"10.1093\/nar\/gks1246","article-title":"DIANA-LncBase: experimentally verified and computationally predicted microRNA targets on long non-coding RNAs","volume":"41","author":"Paraskevopoulou","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ymthe.2017.01.021_bib46","doi-asserted-by":"crossref","first-page":"R90","DOI":"10.1186\/gb-2010-11-8-r90","article-title":"Comprehensive modeling of microRNA targets predicts functional non-conserved and non-canonical sites","volume":"11","author":"Betel","year":"2010","journal-title":"Genome Biol."},{"key":"10.1016\/j.ymthe.2017.01.021_bib47","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/ng1536","article-title":"Combinatorial microRNA target predictions","volume":"37","author":"Krek","year":"2005","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymthe.2017.01.021_bib48","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.neuron.2013.10.062","article-title":"Transcriptome-wide discovery of microRNA binding sites in human brain","volume":"81","author":"Boudreau","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.ymthe.2017.01.021_bib49","doi-asserted-by":"crossref","first-page":"42230","DOI":"10.1074\/jbc.M404931200","article-title":"Structural features of microRNA (miRNA) precursors and their relevance to miRNA biogenesis and small interfering RNA\/short hairpin RNA design","volume":"279","author":"Krol","year":"2004","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ymthe.2017.01.021_bib50","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1261\/rna.783108","article-title":"MicroRNA expression in the adult mouse central nervous system","volume":"14","author":"Bak","year":"2008","journal-title":"RNA"},{"key":"10.1016\/j.ymthe.2017.01.021_bib51","doi-asserted-by":"crossref","first-page":"e0117488","DOI":"10.1371\/journal.pone.0117488","article-title":"Two novel SNPs in ATXN3 3\u2032 UTR may decrease age at onset of SCA3\/MJD in Chinese patients","volume":"10","author":"Long","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ymthe.2017.01.021_bib52","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1093\/hmg\/ddu532","article-title":"A knockin mouse model of spinocerebellar ataxia type 3 exhibits prominent aggregate pathology\u00a0and aberrant splicing of the disease gene transcript","volume":"24","author":"Ramani","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2017.01.021_bib53","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.nbd.2013.01.019","article-title":"Altered Purkinje cell miRNA expression and SCA1 pathogenesis","volume":"54","author":"Rodriguez-Lebron","year":"2013","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ymthe.2017.01.021_bib54","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1002\/dneu.20989","article-title":"Inclusion of a portion of the native SNCA 3\u2032UTR reduces toxicity of human S129A SNCA on striatal-projecting dopamine neurons in rat substantia nigra","volume":"72","author":"Khodr","year":"2012","journal-title":"Dev. Neurobiol."},{"key":"10.1016\/j.ymthe.2017.01.021_bib55","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1093\/hmg\/11.9.1075","article-title":"YAC transgenic mice carrying pathological alleles of the MJD1 locus exhibit a mild and slowly progressive cerebellar deficit","volume":"11","author":"Cemal","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2017.01.021_bib56","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.nbd.2014.09.020","article-title":"A new humanized ataxin-3 knock-in mouse model combines the genetic features, pathogenesis of neurons and glia and late disease onset of SCA3\/MJD","volume":"73","author":"Switonski","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ymthe.2017.01.021_bib57","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1002\/glia.22483","article-title":"Evidence for miR-181 involvement in neuroinflammatory responses of astrocytes","volume":"61","author":"Hutchison","year":"2013","journal-title":"Glia"},{"key":"10.1016\/j.ymthe.2017.01.021_bib58","doi-asserted-by":"crossref","first-page":"e58639","DOI":"10.1371\/journal.pone.0058639","article-title":"MiR-181a regulates inflammation responses in monocytes and macrophages","volume":"8","author":"Xie","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ymthe.2017.01.021_bib59","doi-asserted-by":"crossref","first-page":"220","DOI":"10.3389\/fncel.2013.00220","article-title":"miR-9: a versatile regulator of neurogenesis","volume":"7","author":"Coolen","year":"2013","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.ymthe.2017.01.021_bib60","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3233\/JAD-2008-14103","article-title":"Identification of miRNA changes in Alzheimer\u2019s disease brain and CSF yields putative biomarkers and insights into disease pathways","volume":"14","author":"Cogswell","year":"2008","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.ymthe.2017.01.021_bib61","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1126\/science.1140481","article-title":"A MicroRNA feedback circuit in midbrain dopamine neurons","volume":"317","author":"Kim","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2017.01.021_bib62","doi-asserted-by":"crossref","first-page":"e331","DOI":"10.1038\/mtna.2016.47","article-title":"Altered levels of microRNA-9, \u2212206, and \u2212132 in spinal muscular atrophy and their response to antisense oligonucleotide therapy","volume":"5","author":"Catapano","year":"2016","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.ymthe.2017.01.021_bib63","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1084\/jem.20070823","article-title":"Cerebellar neurodegeneration in the absence of microRNAs","volume":"204","author":"Schaefer","year":"2007","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.ymthe.2017.01.021_bib64","doi-asserted-by":"crossref","first-page":"347ra94","DOI":"10.1126\/scitranslmed.aaf5660","article-title":"An miRNA-mediated therapy for SCA6 blocks IRES-driven translation of the CACNA1A second cistron","volume":"8","author":"Miyazaki","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2017.01.021_bib65","doi-asserted-by":"crossref","first-page":"11445","DOI":"10.1038\/ncomms11445","article-title":"Caloric restriction blocks neuropathology and motor deficits in Machado-Joseph disease mouse models through SIRT1 pathway","volume":"7","author":"Cunha-Santos","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2017.01.021_bib66","doi-asserted-by":"crossref","first-page":"28220","DOI":"10.1038\/srep28220","article-title":"Fibroblasts of Machado Joseph disease patients reveal autophagy impairment","volume":"6","author":"Onofre","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2017.01.021_bib67","series-title":"Dissecting the Pathogenesis of Machado-Joseph Disease in a New Human Disease Model Derived from Induced Pluripotent Stem Cells. Faculty of Pharmacy, vol. PhD","author":"Onofre","year":"2016"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001617300552?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001617300552?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,8]],"date-time":"2024-06-08T06:28:33Z","timestamp":1717828113000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001617300552"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":67,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["S1525001617300552"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2017.01.021","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unravelling Endogenous MicroRNA System Dysfunction as a New Pathophysiological Mechanism in Machado-Joseph Disease","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2017.01.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}